{
    "code": "51061453",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51061453",
    "time": "2023-09-14 22:16:47",
    "許可證字號": "衛部藥製字第061453號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/04\/28",
    "發證\/登錄日期": "112\/04\/28",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05106145308",
    "中文品名": "彌多妥軟膠囊25毫克",
    "英文品名": "Midokemia soft capsule 25mg",
    "適應症": "1. 於新確診為FLT3突變陽性的急性骨髓性白血病(AML)成人病人之標準前導(daunorubicin併用cytarabine)與鞏固性化療(高劑量cytarabine)時合併使用Midostaurin。2. 治療侵犯性全身性肥大細胞增生症(aggressive systemic mastocytosis; ASM)、伴隨血液腫瘤之全身性肥大細胞增生症(systemic mastocytosis with associated hematological neoplasm; SM-AHN)或肥大細胞白血病(mast cell leukemia; MCL)成人病人。",
    "劑型": "132軟膠囊劑",
    "包裝": "8-1000錠OPA\/ALU\/PVC-ALU鋁箔盒裝 8-1000錠OPA\/ALU\/PVC-PET\/ALU\/HSL鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "Midostaurin",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "美時化學製藥股份有限公司",
    "申請商地址": "臺北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "美時化學製藥股份有限公司南投廠",
            "製造廠廠址": "南投縣南投市新興里成功一路３０號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013006900",
            "成分名稱": "Midostaurin",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ]
}